Laparoscopic Versus Open Surgery for the Management of Cystic Echinococcosis of the Liver

July 16, 2012 updated by: Mehmet Kaplan, Medical Park Gaziantep Hospital

Laparoscopic Versus Open Conservative Surgery for the Management of Cystic Echinococcosis of the Liver: Prospective, Randomized, and Controlled Clinical Trial of Efficacy and Safety

Echinococcosis in humans is a parasitic tapeworm infection, caused by a larval stage (the metacestode) of Echinococcus species. The infection can be asymptomatic or severe, causing extensive organ damage and even death of the patient.

Echinococcosis is one of the most neglected parasitic diseases and the lack of the prospective randomised studies supports this idea. Development of new drugs and other treatment modalities receives very little attention, if any. In most developed countries, Cystic Echinococcosis (CE) is an imported disease of very low incidence and prevalence and is found almost exclusively in migrants from endemic regions. In endemic regions, predominantly settings with limited resources, patient numbers are high.

The aim of the hydatid cyst treatment is the death of the parasite and consequently the cure of the disease. It has to be done with a minimal risk and maximum comfort for the patient, and always paying attention to avoid complications, secondary hydatidosis, and relapses.

There are several treatment modalities. Of them the most preferred surgical method is traditional cyst management through a laparotomy incision. Same can be done with laparoscopy. In the past 15 years significant advances in laparoscopic surgical skills and techniques combined with explosive advances in laparoscopic technology have encouraged the application of laparoscopy to the evaluation and treatment of solid organs including the liver. There are many studies about the laparoscopic treatment of liver hydatid cyst published in the literature and the feasibility of this procedure has been demonstrated by them. While the majority of them are case reports or case series, there are some relatively large series comparing open versus laparoscopic surgery published in the last decade, which all are not randomized trial.

Study Overview

Detailed Description

This is a multicenter, balanced randomization, double blind, active-controlled, parallel-group, non-inferiority study conducted in Turkey (4 sites).

The objective of this trial is to show there is no difference in rate of recurrence 2 years after laparoscopic as compared to open management of cystic echinococcosis of the liver, by at least M (non-inferiority margin). If PLAP/POP: denotes the cure rate in the laparoscopy group (LAP) / open group (OP), then the following two-sided test problem is assessed:

H0: POP - PLAP >= M (Open Surgery is superior to Laparoscopic surgery) H1: POP - PLAP < M (Laparoscopic surgery is not inferior to open surgery)

Study Type

Interventional

Enrollment (Actual)

350

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gaziantep, Turkey, 27090
        • Hatem Hospital
      • Gaziantep, Turkey, 27090
        • Medical Park Gaziantep Hospital
      • Gaziantep, Turkey, 27100
        • 25 Aralık State Hospital
      • Gaziantep, Turkey, 27100
        • Dr.Ersin Aslan State Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients eighteen year-old or older
  • patients diagnosed as cystic echinococcosis of the liver
  • cyst number less then 3
  • cyst size greater than 3 cm

Exclusion Criteria:

  • previous liver surgery
  • recurrent disease
  • hydatid cyst with multi-organ involvement
  • liver hydatid cyst complicated with infection
  • contraindication for general anesthesia
  • contraindication for laparoscopic surgery
  • patient younger than 18
  • allergy to albendazole

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: laparoscopic surgery
-Laparoscopic surgery group describes the patients treated with laparoscopic surgery
In laparoscopy group three trocars is used. The first is 10 mm and inserted within the umbilicus for telescop, the second is 10 mm and inserted just below the xiphoid process, and third is 5 mm and inserted at the right upper quadrant of the abdomen.
Other Names:
  • Laparoscopy
ACTIVE_COMPARATOR: Open Surgery
-open surgery group describes the patients treated with traditional open surgery
-open surgery group describes the patients treated with traditional open surgery. In open surgery group a right subcostal incision is used.
Other Names:
  • laparotomy
  • open

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
cyst recurrence
Time Frame: 24 months
24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
mortality
Time Frame: 24 months
24 months
intraoperative complications
Time Frame: 24 hours
24 hours
late complications
Time Frame: 24 months
24 months
pain score
Time Frame: Post opertaive 6th hour, 1, 2, and 7th days
VAS scoring scale will be use
Post opertaive 6th hour, 1, 2, and 7th days
patient comfort/satisfaction
Time Frame: 24 months
will be measured in all follow-up examinations using a scale from 0 (worst) to 10 (excellent).
24 months
hospital stay
Time Frame: 10 days
postoperative hospital days
10 days
duration of the operation
Time Frame: 240 minutes
from incision to closure of the skin
240 minutes
quality of life
Time Frame: first week, 1, 6, 12, and 24 month after operation
first week, 1, 6, 12, and 24 month after operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mehmet KAPLAN, MD, Medical Park Gaziantep Hospital, Gaziantep, Turkey

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2006

Primary Completion (ACTUAL)

November 1, 2010

Study Completion (ACTUAL)

May 1, 2012

Study Registration Dates

First Submitted

June 26, 2012

First Submitted That Met QC Criteria

July 16, 2012

First Posted (ESTIMATE)

July 17, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

July 17, 2012

Last Update Submitted That Met QC Criteria

July 16, 2012

Last Verified

July 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Echinococcosis, Hepatic

Clinical Trials on laparoscopic surgery

3
Subscribe